Name: Alto Neuroscience, Inc. (ANRO) Balance Sheet
Creator: FinSpry

Alto Neuroscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Alto Neuroscience, Inc. (ANRO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	168.23	82.55	48.34	25.71
Cash & Short-Term Investments	168.23	82.55	48.34	25.71
Accounts Receivable	0.00	0.01	0.33	1.74
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	1.08	0.52	0.33	0.24
Total Current Assets	169.34	85.39	49.22	27.68
Non-Current Assets
Property, Plant & Equipment (Net)	7.70	1.23	1.58	1.06
Long-Term Investments	0.50	0.00	0.00	0.00
Other Non-Current Assets	0.50	0.01	0.06	0.05
Total Non-Current Assets	8.21	1.24	1.63	1.11
Total Assets	177.54	86.63	50.85	28.79
Current Liabilities
Accounts Payable	1.58	1.07	1.61	0.60
Short-Term Debt	0.87	0.00	0.00	0.00
Accrued Liabilities	7.56	3.50	3.67	0.93
Other Current Liabilities	7.56	0.92	0.00	0.28
Total Current Liabilities	10.01	5.61	5.56	1.81
Non-Current Liabilities
Long-Term Debt	11.56	9.86	9.47	0.00
Other Non-Current Liabilities	0.00	1.35	0.12	0.00
Total Non-Current Liabilities	16.07	11.21	83.70	39.46
Total Liabilities	26.08	15.47	15.15	1.81
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-138.40	-76.97	-40.66	-12.95
Accumulated Other Comprehensive Income	-0.10	-0.08	-0.05	-0.02
Additional Paid-in Capital	289.95	5.37	2.30	0.49
Shares Outstanding	26.99	25.57	25.57	25.57
Total Stockholders' Equity	151.46	71.16	35.71	26.98
Total Liabilities & Equity	177.54	86.63	50.85	28.79